Streetbeat News

Stock Prices

ADM

Archer-Daniels Midland (ADM) shares are trading higher following the announcement of its Q4 financial results and the issuance of FY24 guidance. Additionally, ADM has authorized an additional $2 billion for its share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:33 am

NHI

BMO Capital analyst John Kim upgraded National Health Investors (NYSE:NHI) from Market Perform to Outperform with a new price target of $67.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:33 am

MNSO

MINISO Group Holding (NYSE:MNSO) reported Q2 earnings and revenue that exceeded Wall Street expectations, with significant year-over-year growth in revenue, gross profit, and adjusted net profit. The company also announced a special cash dividend and plans for aggressive store expansion and revenue growth over the next five years. Shares surged 11.38% in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

March 12, 2024 | 11:30 am

BTCUSD

Market analyst Todd Gordon, founder of Inside Edge Capital, discussed Bitcoin's performance on CNBC's 'Last Call,' highlighting its resilience compared to the sharp decline in semiconductor stocks. Despite Bitcoin's recent surge to over $72,000, Gordon does not believe it is overvalued and sees potential for further growth, especially in relation to tech and semiconductor stocks. He mentioned owning Bitcoin and Bitcoin ETFs, considering adding Bitcoin to his wealth management portfolios.

Portfolio Pulse from Benzinga Neuro

March 12, 2024 | 11:29 am

KSS

Kohl's reported a 4.3% decrease in Q4 comparable sales, indicating a potential challenge in the retail sector.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:15 am

ADM

Archer-Daniels-Midland (ADM) projects its 2024 adjusted EPS to be between $5.25 and $6.25, which is an 18% decrease from 2023, due to moderating margin conditions and higher costs despite improved volumes.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:15 am

FGEN

GSAT

OTLK

REAL

Insiders at FibroGen, RealReal, Outlook Therapeutics, and Globalstar have recently made significant purchases of their companies' stocks, signaling potential confidence in their respective companies' futures. These transactions come amidst various company developments, including new appointments, financial results, and revenue guidance.

Portfolio Pulse from Avi Kapoor

March 12, 2024 | 11:14 am

DG

JP Morgan analyst Matthew Boss upgrades Dollar General (NYSE:DG) from Underweight to Neutral and increases the price target from $120 to $158.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:14 am

JBLU

JetBlue has updated its Q1 forecasts, showing improvements in ASMs and YoY revenue projections, but expects higher fuel prices. ASMs are now expected to be between -4% and -3%, better than the previous estimate of -6% to -3%. Fuel price per gallon is forecasted to be between $2.93 and $3.03, slightly higher than the prior estimate of $2.87 to $3.02. Year-over-year revenue is anticipated to decline by 7.5% to 4.5%, an improvement from the earlier forecast of a 9% to 5% decrease.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:10 am

ETRN

Wells Fargo analyst Michael Blum upgraded Equitrans Midstream (ETRN) from Underweight to Equal-Weight and increased the price target from $10 to $12.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:08 am